NCT Number: NCT07074600
The purpose of this clinical trial is to investigate the efficacy of electroacupuncture therapy for limb dysfunction in ischemic stroke patients residing at high-altitude regions. This study aims to address the following research questions: 1. Whether electroacupuncture therapy demonstrates clinical effectiveness in managing limb dysfunction among ischemic stroke patients in high-altitude regions. 2. Whether electroacupuncture therapy maintains an acceptable safety profile in this specific population.
Researchers will conduct a comparative analysis between the active electroacupuncture intervention group and a sham-electroacupuncture control group to evaluate therapeutic efficacy. Participants will: 1. Undergo daily electroacupuncture treatment sessions for a standardized 14-day therapeutic course. 2. Complete comprehensive functional assessments and neurological evaluations at baseline and post-intervention timepoints.
Trial opening soon.
Get Notified18 year–75 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants in the experimental group will receive daily electroacupuncture therapy over a standardized 14-day therapeutic course. Comprehensive functional and neurological assessments will be conducted at pre-intervention (baseline) and post-intervention timepoints. Acupoint selection will target anatomical domains spanning the cranial, upper limb, and lower limb regions.
Other names: Electroacupuncture
Participants in the control group will receive daily sham electroacupuncture therapy over a standardized 14-day therapeutic course. Comprehensive functional and neurological assessments will be conducted at pre-intervention (baseline) and post-intervention timepoints. Sham electroacupuncture procedures will target non-acupoint locations outside recognized cranial, upper limb, and lower limb anatomical domains.
Other names: Sham electroacupuncture
Time frame: "Baseline"，"Day 7"，"Day 14"
Time frame: "Baseline"，"Day 7"，"Day 14"
Assessments were conducted at baseline (pre-intervention), day 7 of treatment, and post-intervention. The evaluation comprises 33 items for upper extremity motor function and 17 items for lower extremity motor function. Each item is scored 2 points for full completion, 1 point for partial completion, and 0 points for inability to complete. The total score ranges from 0 to 66 for upper extremities and 0 to 34 for lower extremities, with higher scores indicating better motor function.
Time frame: "Baseline"，"Day 7"，"Day 14"
Assessments were conducted at baseline (pre-intervention), day 10 of treatment, and post-intervention. The ADL assessment scale is primarily used to evaluate the activities of daily living and functional status in stroke patients, encompassing 11 items related to 10 fundamental aspects of self-care and mobility. Each item is scored on a scale of 0 to 15 points, with the sum of all items constituting the ADL score. Higher scores indicate better daily living ability.
Contact information is provided by the study sponsor or research team.
Kaiyang Zheng
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
